In vitro and in vivo oxidative biotransformation in the West-African dwarf goat (Caprus hircus aegagrus): Substrate activities and effects of inducers

Xenobiotica

Volumn 26, Issue 11, 1996, Pages 1131-1141

  Zweers Zeilmaker, W M ^a   Batzias, J ^b   Maas, R F M ^a   Horbach, G J ^a   Van Miert, A S J P A M ^a   Witkamp, R F ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

APOPROTEIN; BETA NAPHTHOFLAVONE; CAFFEINE; CYTOCHROME P450; ISONIAZID; PHENAZONE; PHENOBARBITAL; SULFADIMIDINE; TROLEANDOMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; DRUG CLEARANCE; DRUG METABOLISM; DRUG OXIDATION; ENZYME INDUCTION; ENZYME SUBSTRATE COMPLEX; FEMALE; GOAT; IN VITRO STUDY; IN VIVO STUDY; LIVER MICROSOME; NONHUMAN; ORAL DRUG ADMINISTRATION;

ANIMALIA; CAPRA HIRCUS; CINCHONA PUBESCENS;

EID: 0029860247     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.3109/00498259609050258     Document Type: Article

References (42)

1. BACK, D. J., TJIA, J., MÖNIG, H., OHNAUS, E. E., and PARK, B. K., 1988, Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamide. European Journal of Clinical Pharmacology, 34, 157-163.
2. BERTHOU, F., GUILLOIS, B., RICHE, C., DREANO, Y., JACQZ-AIGRAIN, E., and BEAUNE, P. H., 1992, Interspecies variations in caffeine metabolism related to cytochrome P4501A enzymes. Xenobiotica, 22, 671-680.
3. pa (P4501A2), the phenacetin o-deethylase is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proceedings of the National Academy of Sciences, USA, 86, 7696-7700.
4. CHHABRA, R. S., GRAM, T. E., and FOUTS, J. R., 1972, A comparative study of two procedures used in the determination of hepatic microsomal aniline hydroxylation. Toxicology and Applied Pharmacology, 22, 50-58.
5. GEE, S. J., GREEN, C. E., and TYSON, C. A., 1984, Comparative metabolism of tolbutamide by isolated hepatocytes from rat, rabbit, dog and squirrel monkey. Drug Metabolism and Disposition, 12, 174-178.
6. GOGH VAN, H., DEURZEN VAN, E. J. M., DUIN VAN, C. T. M., and MIERT VAN, A. S. J. P. A. M., 1984, Effect of staphylococcal enterotoxin B-induced diarrhoea on the pharmacokinetics of sulphadimidine in the goat. Journal of Veterinary Pharmacology and Therapeutics, 7, 303-305.
7. GOUBIER, C., GIRARD, I., and FERRY, S., 1991, High-performance liquid chromatographic assay of debrisoquine and its 4-hydroxy metabolite in human urine. Chromatographia, 32, 523-526.
8. HEINZEL, G., WOLOSZCAK, R., and THOMANN, P. (eds), 1993, TopFit 2-0. Pharmacokinetic and Pharmacodynamic Data Analysis System for the PC (Stuttgart: Gustav Fischer).
9. IMAI, Y., ITO, A., and SATO, R., 1966, Evidence for biochemically different types of vesicles in the hepatic microsomal fraction. Journal of Biochemistry, 60, 417-428.
10. KATO, R., 1979, Characteristics and differences in the hepatic mixed function oxidases of different species. Pharmacology and Therapeutics, 6, 41-98.
11. KLOOSTER VAN 'T, G. A. E., HORBACH, G. J. M. J., NATSUHORI, M., BLAAUBOER, B. J., NOORDHOEK, J., and MIERT VAN, A. S. J. P. A. M., 1993, Hepatic cytochrome P450 induction in goats: effects of model inducers on the metabolism of alkoxyresorufins, testosterone end ethylmorphine, and on apoprotein and mRNA levels. Biochemical Pharmacology, 45, 113-122.
12. 4-acetyl sulphadimidine in body fluids and cell culture media. Journal of Chromatography, Biomedical Applications, 571, 157-168.
13. KOOP, D. R., CRUMP, B. L., NORDBLOM, G. D., and COON, M. J., 1985, Immunochemical evidence for induction of the alcohol-oxidizing cytochrome P-450 of rabbit liver microsomes by diverse agents: ethanol, imidazole, trichloroethylene, acetone, pyrazole, and isoniazid. Proceedings of the National Academy of Sciences, USA, 82, 4065-4069.
14. LAEMMLI, U. K., 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
15. LARREY, D., DISTLERATH, L. M., DANNAN, G. A., WILKINSON, G. R., and GUENGERICH, F. P., 1984, Purification and characterization of the rat liver microsomal cytochrome P450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism. Biochemistry, 23, 2787-2795.
16. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L., and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
17. LUBET, R. A., MAYER, R. T., CAMERON, J. W., NIMS, R. W., BURKE, M. D., WOLFE, T., and GUENGERICH, F. P., 1985, Dealkylation of pentoxyresorufin : a rapid and sensitive assay for measuring induction of cytochrome(s) P450 by phenobarbital and other xenobiotics in the rat. Archives of Biochemistry and Biophysics, 238, 43-48.
18. MATSUO, Y. IWAHASHI, K., and ICHIKAWA, Y., 1992, Debrisoquine 4-monooxygenase and bufuralol 1′-monooxygenase activities in bovine and rabbit tissues. Biochemical Pharmacology, 43, 1911-1919.
19. MONSHOUWER, M., WITKAMP, R. F., NIJMEIJER, S. M., LEENGOED VAN, L. A. M. G., VERHEIJDEN, J. H. M., and MIERT VAN, A. S. J. P. A. M., 1995, Infection (Actinobacillus pleuropneumoniae) mediated suppression of oxidative hepatic drug metabolism and cytochrome P4503A mRNA levels in pigs. Drug Metabolism and Disposition, 23, 44-47.
20. MURRAY, M., 1991, Microsomal cytochrome P450-dependent steroid metabolism in male sheep liver. Quantitative importance of 6β-hydroxylation and evidence for the involvement of a P450 from the IIIA subfamily in the pathway. Journal of Steroid Biochemistry and Molecular Biology, 38, 611-619.
21. NATSUHORI, M., WITKAMP, R. F., KLOOSTER VAN 'T, G. A. E., and MIERT VAN, A. S. J. P. A. M., 1992, Metabolism of antipyrine and sulphadimidine in dwarf goats: effects of the enzyme inducing agents phenobarbital, troleandomycin and rifampicin. Xenobiotica, 25, 491-199.
22. RELLING, M. V., AOYAMA, T., GONZALES, F. J., and MEYER, U. A., 1990, Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily. Journal of Pharmacology and Experimental Therapeutics, 252, 442-447.
23. RUTTEN, A. A. J. J. L., FALKE, H. E., CATSBURG, J. F., TOPP, R., BLAAUBOER, B. J., HOLSTEYN VAN, I., DOORN, L., and LEEUWEN VAN, F. X. R., 1987, Interlaboratory comparison of total cytochrome P450 and protein determinations in rat liver microsomes. Archives of Toxicology, 61, 27-33.
24. RUTTEN, A. A. J. J. L., FALKE, H. E., CATSBURG, J. F., WORTELBOER, H. M., BLAAUBOER, B. J., DOORN, L., LEEUWEN VAN, F. X. R., THEELEN, R., and RIETJENS, I. M. C. M., 1992, Interlaboratory comparison of microsomal ethoxyresorutin and pentoxyresorufin O-dealkylation determinations - standardization of assay conditions. Archives of Toxicology, 66, 237-244.
25. RYAN, D. E., KOOP, D. R., THOMAS, P. E., COON, M. J., and LEVIN, W., 1986, Evidence that isoniazid and ethanol induce the same microsomal cytochrome P-450 in rat liver, an isozyme homologous to rabbit liver cytochrome P-450 isozyme 3a. Archives of Biochemistry and Biophysics, 246, 663-644.
26. SCHELLENS, J. H. M., VAN DER WART, J. H. F., BRUGMAN, M., and BREIMER, D. D., 1989, Influence of enzyme induction and inhibition on the oxidation of nifedipine, sparteine, mephenytoin and antipyrine in humans as assessed by a 'cocktail' study design. Journal of Pharmacology and Experimental Therapeutics, 249, 638-645.
27. SHARER, J. A. and WRIGHTON, S. A., 1996, Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine. Drug Metabolism and Disposition, 24, 487-494.
28. SHIMADA, M. S., MURAYAMA, N., YAMAZOE, Y., HASHIMOTO, H., ISHIKAWA, H., and KATO, R., 1995, Age- and sex-related alterations of microsomal drug- and testosterone-oxidizing cytochrome P450 in Sprague-Dawley strain-derived dwarf rats. Journal of Pharmacology and Experimental Therapeutics, 275, 972-977.
29. SMITH, D. A., 1991, Species differences in metabolism and pharmacokinetics: are we close to understanding? Drug Metabolism Reviews, 23, 355-373.
30. TEUNISSEN, M. W. E., VAN DER MEEBBURG-TORREN, J. E., VERMEULEN, N. P. E., and BREIMER, D. D., 1983, Automated HPLC-determination of antipyrine and its main metabolites in plasma, saliva and urine including 4,4′-dihydroxy antipyrine. Journal of Chromatography (Biomedical Applications), 278, 367-378.
31. TOWBIN, H., STAEHELIN, T., and GORDON, J., 1979, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, USA, 76, 4350-4354.
32. VERONESE, M. E., MACKENZIE, P. E., DOECKE, C. J., MCMANUS, M. E., MINERS, J. O., and BIRKETT, D. J., 1991, Tolbutamide and phenytion hydroxylation by cDNA expressed human liver cytochrome P4502C9. Biochemical and Biophysical Research Communications, 175, 1112-1118.
33. VERONESE, M. E., MCMANUS, M. E., LAUPATTARAKASEM, P., MINERS, J. O., and BIRKETT, D. J., 1990, Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P450. Drug Metabolism and Disposition, 18, 356-361.
34. WEAVER, R. J., THOMPSON, S., SMITH, G., DICKINS, M., ELCOMBE, C. R., MAYER, R. T., and BURKE, D., 1994, A comparative study of constitutive and induced alkoxyresorufin O-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes. Biochemical Pharmacology, 47, 763-773.
35. WITKAMP, R. F., KLOOSTER, VAN 'T, G. A. E., NIJMEIJER, S. M., KOLKER, H. J., NOORDHOEK, J., and MIERT VAN, A. S. J. P. A. M., 1993a, Hormonal regulation of oxidative drug metabolism in the dwarf goat. The effects of sex and hormonal treatment on plasma disposition and metabolite formation of sulphadimidine. Journal of Veterinary Pharmacology and Therapeutics, 16, 55-62.
36. WITKAMP, R. F., LOHUIS, J. A. C. M., NIJMEIJER, S. M., KOLKER, H. J., NOORDHOEK, J., and MIERT VAN, A. S. J. P. A. M., 1992, Species- and sex-related differences in the plasma clearance and metabolite formation of antipyrine. A comparative study in four animal species: cattle, goat, rat and rabbit. Xenobiotica, 21, 1483-1492.
37. WITKAMP, R. F., NIJMEIJER, S. M., YUN, H-I., KOLKER, H. J., NOORDHOEK, J., and MIERT VAN, A. S. J. P. A. M., 1993b, Sulfamethazine as a model compound to assess sex-hormone-dependent cytochrome P-450 activity in rats. Drug Metabolism and Disposition, 21, 441-446.
38. WOLKERS, J., JORGENSEN, E. H., NIJMEIJER, S. M., and WITKAMP, R. F., 1996, Time dependent induction of two distinct hepatic cytochrome P4501A catalytic activities at low temperatures in Arctic charr (Salvelinus alpinus) after oral exposure to benzo(a)pyrene. Aquatic Toxicology (in press).
39. WORTELBOER, H. M., KRUIF DE C. A., IERSEL VAN, A. A. J., FALKE, H. E., NOORDHOEK, J., and BLAAUBOER, B. J., 1991, Comparison of cytochrome P450 isoenzyme profiles in rat liver and hepatocyte cultures : the effects of model inducers on apoproteins and biotransformation activities. Biochemical Pharmacology, 42, 381-390.
40. WORTELBOER, H. M., KRUIF DE C. A., IERSEL VAN, A. A. J., FALKE, H. E., NOORDHOEK, J., and BLAAUBOER, B. J., 1990, The isoenzyme pattern of cytochrome P450 in rat hepatocytes in primary culture, comparing different enzyme activities in microsomal incubations and in intact monolayers. Biochemical Pharmacology, 40, 2525-2534.
41. ZEILMAKER, W. M., KLOOSTER VAN 'T, G. A. E., FINK GREMMELS-GEHRMANN, J., MIERT VAN, A. S. J. P.-A. M., and HORBACH, G. J. M. J., 1994, cDNA and deduced amino acid sequence of a dwarf goat liver cytochrome P450 fragment belonging to the CYP2C gene subfamily. Biochemical and Biophysical Research Communications, 200, 120-125.
42. ZWEERS-ZEILMAKER, W. M., MAAS, R. F. M., HORBACH, G. J., VAN MIERT, A. S. J. P. A. M., and WITKAMP, R. F., 1996, Cytochrome P4502E in vivo and in vitro in the dwarf goat: Effects of enzyme induction and the applicability of chlorzoxazone as markersubstrate. Journal of Veterinary Pharmacology and Therapeutics, 19, 245-250.